{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:18:09Z","timestamp":1793852289701,"version":"4.6.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100010748","name":"Deutsche Gesellschaft f\u00fcr Zahn-, Mund- und Kieferheilkunde","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12967-017-1230-8","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T12:57:13Z","timestamp":1496753833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3276-6505","authenticated-orcid":false,"given":"Christian","family":"Gross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Creutzburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"M\u00f6bius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimund","family":"Preidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Wehrhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"issue":"1","key":"1230_CR1","first-page":"113","volume":"35","author":"K Tomihara","year":"2008","unstructured":"Tomihara K, et al. Osteomyelitis of the jaw in breast cancer patients receiving bisphosphonate therapy. Gan To Kagaku Ryoho. 2008;35(1):113\u20136.","journal-title":"Gan To Kagaku Ryoho"},{"issue":"5 Suppl","key":"1230_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joms.2008.10.005","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development. J Oral Maxillofac Surg. 2009;67(5 Suppl):13\u20138.","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1230_CR3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14219\/jada.archive.2008.0017","volume":"139","author":"JT Grbic","year":"2008","unstructured":"Grbic JT, et al. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial. J Am Dent Assoc. 2008;139(1):32\u201340.","journal-title":"J Am Dent Assoc"},{"issue":"32","key":"1230_CR4","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol. 2009;27(32):5356\u201362.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1230_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"JC Lo","year":"2010","unstructured":"Lo JC, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010;68(2):243\u201353.","journal-title":"J Oral Maxillofac Surg"},{"key":"1230_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-160X-6-11","volume":"6","author":"C Walter","year":"2010","unstructured":"Walter C, et al. Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients. Head Face Med. 2010;6:11.","journal-title":"Head Face Med"},{"issue":"5","key":"1230_CR7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2008.06.070","volume":"54","author":"C Walter","year":"2008","unstructured":"Walter C, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol. 2008;54(5):1066\u201372.","journal-title":"Eur Urol"},{"issue":"9","key":"1230_CR8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115\u20137.","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"1230_CR9","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00784-014-1205-6","volume":"18","author":"C Walter","year":"2014","unstructured":"Walter C, et al. Analysis of reasons for osteonecrosis of the jaws. Clin Oral Investig. 2014;18(9):2221\u20136.","journal-title":"Clin Oral Investig"},{"issue":"1","key":"1230_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30(1):3\u201323.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"1230_CR11","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.joms.2010.05.090","volume":"68","author":"MR Allen","year":"2010","unstructured":"Allen MR, Pandya B, Ruggiero SL. Lack of correlation between duration of osteonecrosis of the jaw and sequestra tissue morphology: what it tells us about the condition and what it means for future studies. J Oral Maxillofac Surg. 2010;68(11):2730\u20134.","journal-title":"J Oral Maxillofac Surg"},{"issue":"7","key":"1230_CR12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.joms.2009.03.048","volume":"67","author":"MR Allen","year":"2009","unstructured":"Allen MR, Ruggiero SL. Higher bone matrix density exists in only a subset of patients with bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2009;67(7):1373\u20137.","journal-title":"J Oral Maxillofac Surg"},{"key":"1230_CR13","unstructured":"Topazian RG, Osteomyelitis of jaws. In: T.R.G.G.M. H, editor. Oral and maxillofacial infections. 1994. Philadelphia: Saunders. p. 51\u2013286."},{"issue":"6","key":"1230_CR14","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.tripleo.2005.02.077","volume":"99","author":"P Scolozzi","year":"2005","unstructured":"Scolozzi P, et al. Enteric bacteria mandibular osteomyelitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2005;99(6):e42\u20136.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"issue":"2","key":"1230_CR15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1042-3699(20)30505-7","volume":"3","author":"RE Marx","year":"1991","unstructured":"Marx RE. Chronic osteomyelitis of the jaws. Oral Maxillofac Clin N Am. 1991;3(2):367\u201381.","journal-title":"Oral Maxillofac Clin N Am"},{"key":"1230_CR16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1042-3699(20)30504-5","volume":"3","author":"LG Mercuri","year":"1991","unstructured":"Mercuri LG. Acute osteomyelitis of the jaws. Oral Maxillofac Surg Clin N Am. 1991;3:355\u201365.","journal-title":"Oral Maxillofac Surg Clin N Am"},{"issue":"5","key":"1230_CR17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1046\/j.1365-2273.2000.00367.x","volume":"25","author":"G Store","year":"2000","unstructured":"Store G, Boysen M. Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects. Clin Otolaryngol Allied Sci. 2000;25(5):378\u201384.","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"1","key":"1230_CR18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tripleo.2011.07.042","volume":"113","author":"S Nabil","year":"2012","unstructured":"Nabil S, Samman N. Risk factors for osteoradionecrosis after head and neck radiation: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(1):54\u201369.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"1230_CR19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.otohns.2009.12.008","volume":"142","author":"JD Suh","year":"2010","unstructured":"Suh JD, et al. Disease relapse after segmental resection and free flap reconstruction for mandibular osteoradionecrosis. Otolaryngol Head Neck Surg. 2010;142(4):586\u201391.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"1230_CR20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00066-004-1171-z","volume":"180","author":"G Studer","year":"2004","unstructured":"Studer G, Gr\u00e4tz KW, Glanzmann C. Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlenther Onkol. 2004;180(4):233\u201340.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1230_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJMoa0802633","volume":"360","author":"RS Weinstein","year":"2009","unstructured":"Weinstein RS, Roberson PK, Manolagas SC. Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med. 2009;360(1):53\u201362.","journal-title":"N Engl J Med"},{"key":"1230_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1472-6890-14-31","volume":"14","author":"F Mac-Way","year":"2014","unstructured":"Mac-Way F, et al. Giant osteoclasts in patients under bisphosphonates. BMC Clin Pathol. 2014;14:31.","journal-title":"BMC Clin Pathol"},{"issue":"1","key":"1230_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","volume":"49","author":"MJ Rogers","year":"2011","unstructured":"Rogers MJ, et al. Biochemical and molecular mechanisms of action of bisphosphonates. Bone. 2011;49(1):34\u201341.","journal-title":"Bone"},{"key":"1230_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-59745-104-8_4","volume":"455","author":"T Bellido","year":"2008","unstructured":"Bellido T, Plotkin LI. Detection of apoptosis of bone cells in vitro. Methods Mol Biol. 2008;455:51\u201375.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"1230_CR25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1006\/bbrc.2000.2229","volume":"268","author":"F Lorget","year":"2000","unstructured":"Lorget F, et al. High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem Biophys Res Commun. 2000;268(3):899\u2013903.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1230_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2302\/kjm.60.101","volume":"60","author":"T Miyamoto","year":"2011","unstructured":"Miyamoto T. Regulators of osteoclast differentiation and cell-cell fusion. Keio J Med. 2011;60(4):101\u20135.","journal-title":"Keio J Med"},{"issue":"12","key":"1230_CR27","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/1521-4141(200012)30:12<3585::AID-IMMU3585>3.0.CO;2-Y","volume":"30","author":"FC Hartgers","year":"2000","unstructured":"Hartgers FC, et al. DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur J Immunol. 2000;30(12):3585\u201390.","journal-title":"Eur J Immunol"},{"issue":"4","key":"1230_CR28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00774-013-0434-0","volume":"31","author":"Z Zeng","year":"2013","unstructured":"Zeng Z, Zhang C, Chen J. Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts. J Bone Miner Metab. 2013;31(4):409\u201316.","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"1230_CR29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.20050645","volume":"202","author":"M Yagi","year":"2005","unstructured":"Yagi M, et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med. 2005;202(3):345\u201351.","journal-title":"J Exp Med"},{"issue":"7","key":"1230_CR30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.20040518","volume":"200","author":"T Kukita","year":"2004","unstructured":"Kukita T, et al. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med. 2004;200(7):941\u20136.","journal-title":"J Exp Med"},{"issue":"1","key":"1230_CR31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jbmr.531","volume":"27","author":"YH Chiu","year":"2012","unstructured":"Chiu YH, et al. Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). J Bone Miner Res. 2012;27(1):79\u201392.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1230_CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/me.2007-0237","volume":"22","author":"K Kim","year":"2008","unstructured":"Kim K, et al. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol. 2008;22(1):176\u201385.","journal-title":"Mol Endocrinol"},{"issue":"1","key":"1230_CR33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jcp.22012","volume":"223","author":"KA Mensah","year":"2010","unstructured":"Mensah KA, Ritchlin CT, Schwarz EM. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens. J Cell Physiol. 2010;223(1):76\u201383.","journal-title":"J Cell Physiol"},{"issue":"8","key":"1230_CR34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/104454902320308915","volume":"21","author":"J Rho","year":"2002","unstructured":"Rho J, et al. Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol. 2002;21(8):541\u20139.","journal-title":"DNA Cell Biol"},{"issue":"3","key":"1230_CR35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.20050645","volume":"202","author":"M Yagi","year":"2005","unstructured":"Yagi M, et al. DC-STAMP is essential for cell\u2013cell fusion in osteoclasts and foreign body giant cells. J Exp Med. 2005;202(3):345\u201351.","journal-title":"J Exp Med"},{"issue":"2","key":"1230_CR36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/002215540004800207","volume":"48","author":"AR Hayman","year":"2000","unstructured":"Hayman AR, et al. Osteoclastic tartrate-resistant acid phosphatase (Acp 5): its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem. 2000;48(2):219\u201328.","journal-title":"J Histochem Cytochem"},{"issue":"6","key":"1230_CR37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/002215540104900601","volume":"49","author":"AR Hayman","year":"2001","unstructured":"Hayman AR, et al. Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells. J Histochem Cytochem. 2001;49(6):675\u201384.","journal-title":"J Histochem Cytochem"},{"issue":"5","key":"1230_CR38","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jcb.20835","volume":"98","author":"B Kirstein","year":"2006","unstructured":"Kirstein B, Chambers TJ, Fuller K. Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behavior. J Cell Biochem. 2006;98(5):1085\u201394.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1230_CR39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00223-001-2122-7","volume":"71","author":"JM Halleen","year":"2002","unstructured":"Halleen JM, et al. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int. 2002;71(1):20\u20135.","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"1230_CR40","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1242\/dev.122.10.3151","volume":"122","author":"AR Hayman","year":"1996","unstructured":"Hayman AR, et al. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development. 1996;122(10):3151\u201362.","journal-title":"Development"},{"issue":"2","key":"1230_CR41","first-page":"496","volume":"7","author":"KT Mitsimponas","year":"2014","unstructured":"Mitsimponas KT, et al. Osteo-radio-necrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ): the histopathological differences under the clinical similarities. Int J Clin Exp Pathol. 2014;7(2):496\u2013508.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"1230_CR42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijom.2011.12.016","volume":"41","author":"RE Marx","year":"2012","unstructured":"Marx RE, Tursun R. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease. Int J Oral Maxillofac Surg. 2012;41(3):283\u20139.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"3","key":"1230_CR43","doi-asserted-by":"crossref","first-page":"551","DOI":"10.17779\/KAOMP.2015.39.3.551","volume":"39","author":"TM You","year":"2015","unstructured":"You TM, Kim HS. Histopathologic comparison of osteomyelitis, osteoradionecrosis, medication-related osteonecrosis of the jaw. Korean J Oral Maxillofac Pathol. 2015;39(3):551\u20138.","journal-title":"Korean J Oral Maxillofac Pathol"},{"issue":"3","key":"1230_CR44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","volume":"35","author":"T Hansen","year":"2006","unstructured":"Hansen T, et al. Osteonecrosis of the jaws in patients treated with bisphosphonates\u2014histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med. 2006;35(3):155\u201360.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"1230_CR45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bone.2005.04.041","volume":"37","author":"C Yang Li","year":"2005","unstructured":"Yang Li C, et al. High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse. Bone. 2005;37(3):287\u201395.","journal-title":"Bone"},{"issue":"1","key":"1230_CR46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02408534","volume":"32","author":"PH Reitsma","year":"1980","unstructured":"Reitsma PH, et al. Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats. Calcif Tissue Int. 1980;32(1):145\u201357.","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"1230_CR47","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1210\/endo.141.12.7921","volume":"141","author":"JE Fisher","year":"2000","unstructured":"Fisher JE, Rodan GA, Reszka AA. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway. Endocrinology. 2000;141(12):4793\u20136.","journal-title":"Endocrinology"},{"issue":"5","key":"1230_CR48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","volume":"349","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, et al. Bisphosphonate-induced osteopetrosis. N Engl J Med. 2003;349(5):457\u201363.","journal-title":"N Engl J Med"},{"issue":"9","key":"1230_CR49","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","volume":"110","author":"F Rauch","year":"2002","unstructured":"Rauch F, et al. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Investig. 2002;110(9):1293\u20139.","journal-title":"J Clin Investig"},{"issue":"Suppl 2","key":"1230_CR50","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","volume":"119","author":"RG Russell","year":"2007","unstructured":"Russell RG. Bisphosphonates: mode of action and pharmacology. Pediatrics. 2007;119(Suppl 2):S150\u201362.","journal-title":"Pediatrics"},{"issue":"12 Suppl","key":"1230_CR51","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","volume":"88","author":"MJ Rogers","year":"2000","unstructured":"Rogers MJ, et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer. 2000;88(12 Suppl):2961\u201378.","journal-title":"Cancer"},{"issue":"1","key":"1230_CR52","doi-asserted-by":"crossref","first-page":"e28119","DOI":"10.4161\/sgtp.28119","volume":"5","author":"H Touaitahuata","year":"2014","unstructured":"Touaitahuata H, Blangy A, Vives V. Modulation of osteoclast differentiation and bone resorption by Rho GTPases. Small GTPases. 2014;5(1):e28119.","journal-title":"Small GTPases"},{"issue":"6","key":"1230_CR53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"2009","unstructured":"Parfitt AM, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units: report of the asbmr histomorphometry nomenclature committee. J Bone Miner Res. 2009;2(6):595\u2013610.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"1230_CR54","doi-asserted-by":"crossref","first-page":"e0132520","DOI":"10.1371\/journal.pone.0132520","volume":"10","author":"D Heymann","year":"2015","unstructured":"Heymann D, et al. A model for osteonecrosis of the jaw with zoledronate treatment following repeated major trauma. PLoS ONE. 2015;10(7):e0132520.","journal-title":"PLoS ONE"},{"key":"1230_CR55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2014.07.027","volume":"68","author":"RS Molon de","year":"2014","unstructured":"de Molon RS, et al. Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model. Bone. 2014;68:11\u20139.","journal-title":"Bone"},{"issue":"4","key":"1230_CR56","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0022034514564187","volume":"94","author":"Y Nagaoka","year":"2015","unstructured":"Nagaoka Y, et al. Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition. J Dent Res. 2015;94(4):594\u2013601.","journal-title":"J Dent Res"},{"issue":"11","key":"1230_CR57","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.ajpath.2014.07.010","volume":"184","author":"DW Williams","year":"2014","unstructured":"Williams DW, et al. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-kappaB ligand antibody in mice. Am J Pathol. 2014;184(11):3084\u201393.","journal-title":"Am J Pathol"},{"key":"1230_CR58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/1440-1681.12673","volume":"44","author":"R Wang","year":"2016","unstructured":"Wang R, et al. Bone metabolism markers: indicators of loading dose intravenous ibandronate treatment for bone metastases from breast cancer. Clin Exp Pharmacol Physiol. 2016;44:88\u201393.","journal-title":"Clin Exp Pharmacol Physiol."},{"issue":"4","key":"1230_CR59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1600-0765.2006.00876.x","volume":"41","author":"YH Chung","year":"2006","unstructured":"Chung YH, et al. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. J Periodontal Res. 2006;41(4):288\u201396.","journal-title":"J Periodontal Res"},{"issue":"1","key":"1230_CR60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jcp.10041","volume":"190","author":"K Suda","year":"2002","unstructured":"Suda K, et al. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J Cell Physiol. 2002;190(1):101\u20138.","journal-title":"J Cell Physiol"},{"issue":"7","key":"1230_CR61","doi-asserted-by":"crossref","first-page":"e40586","DOI":"10.1371\/journal.pone.0040586","volume":"7","author":"A Widaa","year":"2012","unstructured":"Widaa A, et al. Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis. PLoS ONE. 2012;7(7):e40586.","journal-title":"PLoS ONE"},{"issue":"4","key":"1230_CR62","first-page":"291","volume":"2","author":"BA Scheven","year":"1987","unstructured":"Scheven BA, et al. Direct and indirect radiation effects on osteoclast formation in vitro. Bone Miner. 1987;2(4):291\u2013300.","journal-title":"Bone Miner"},{"issue":"6","key":"1230_CR63","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1089\/jir.2014.0152","volume":"35","author":"JS Alwood","year":"2015","unstructured":"Alwood JS, et al. Ionizing radiation stimulates expression of pro-osteoclastogenic genes in marrow and skeletal tissue. J Interf Cytokine Res. 2015;35(6):480\u20137.","journal-title":"J Interf Cytokine Res"},{"issue":"4","key":"1230_CR64","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00428-006-0261-y","volume":"449","author":"T Hansen","year":"2006","unstructured":"Hansen T, et al. Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis\u2014a paradoxical observation? Virchows Arch. 2006;449(4):448\u201354.","journal-title":"Virchows Arch"},{"issue":"5","key":"1230_CR65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00223-005-0027-6","volume":"77","author":"W Balemans","year":"2005","unstructured":"Balemans W, Van Wesenbeeck L, Van Hul W. A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int. 2005;77(5):263\u201374.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1230_CR66","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","volume":"68","author":"TL Aghaloo","year":"2010","unstructured":"Aghaloo TL, Felsenfeld AL, Tetradis S. Osteonecrosis of the jaw in a patient on Denosumab. J Oral Maxillofac Surg. 2010;68(5):959\u201363.","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1230-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T16:01:24Z","timestamp":1719244884000},"score":1,"resource":{"primary":{"URL":"http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1230-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,6]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1186\/s12967-017-1230-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,6]]},"article-number":"128"}}